Intravenous Catheters Market Size, Share & Trends Analysis Report By Type (Peripheral Catheters, Midline Peripheral Catheters, Central Venous Catheters), By End-use (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

Intravenous Catheters Market Size & Trends

The global intravenous catheters market size was estimated at USD 8.74 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.95% from 2024 to 2030. The demand for intravenous catheters is anticipated to upsurge owing to the increasing regulatory approval for IV catheters, rising incidence of various chronic disorders such as neurological, cardiovascular, and urological disorders along with growing elderly population. In addition, the growing awareness for the catheter-related bloodstream infection (CRBSI) control among the population is also expected to further increase the demand for intravenous catheters over the forecast period.

Intravenous therapy, also known as infusion therapy, is a popular medical treatment for several illnesses, including cancer, infections, and autoimmune disorders. It involves injecting fluids and drugs straight into the bloodstream. As the healthcare sector keeps evolving, one of the most significant developments in recent years has been the increased public awareness of infection control. Healthcare-associated infections (HAIs) are the major cause of mortality among patients. For instance, as per a report published by the WHO in March 2022, HAIs are estimated to be responsible for about 4-56% of all infant deaths in the U.S.

Up to 90% of hospitalized patients receive an IV, making IV lines an essential part of many patients' treatment strategies. However, one of the primary causes of catheter-related bloodstream infections (CRBSI) is inadequate care and maintenance of these devices. Healthcare professionals are opting for IV catheters with low infection risks as they are becoming more conscious regarding infection control. In May 2023, BD launched integrated prefilled flush syringe's customer availability.

To help improve patient care, BD PosiFlush SafeScrub syringe accelerates the clinical process of flushing and disinfecting IV catheters. Flushing and disinfecting IV catheters are essential procedures for preventing CRBSIs. Thus, healthcare professionals are becoming increasingly aware of the importance of infection prevention guidelines, which emphasize the need for proper flushing and disinfecting of IV catheters.

Key players are involved in receiving regulatory approval for the IV catheters, which is driving the market growth. Due to this, patients can have access to new and improved catheters which enhance the quality of life. This also allows the manufacturers to develop novel products for the market. In March 2023, Shockwave Medical, Inc. received U.S. FDA approval for its Shockwave L6 Peripheral IVL Catheter. The catheter was developed specifically to treat calcification in tumors in major peripheral vessels, such as femoral arteries and iliac arteries that are difficult to treat. These arteries frequently develop calcification, which leads to more complications and a lower success rate during endovascular surgeries.

The rising number of diseases involving urology, neurology, and cardiovascular disease, and the increasing use of advanced materials in catheters boost the industry growth. In the past three decades, there has been a rise in the primary factors contributing to global mortality and morbidity, including neurological, urological, and cardiovascular conditions. For instance, as per the data published by American College of Cardiology in July 2023, approximately 200 million people worldwide and more than 12 million people in the U.S. suffer from peripheral artery disease (PAD).

The rising elderly population is one of the significant factors boosting the market over the forecast period. Chronic illnesses such as cancer, diabetes, and heart disease are becoming more common in elderly people and often require IV therapy. As per the reports of WHO published in 2022, around 80% of elderly people by 2050 will reside in nations with a low or middle income. It is anticipated that the number of persons 80 years of age or older will be around 426 million by 2050. As per the report published by National Library of Medicine in 2023, people over 65 are more likely to receive IV treatment simultaneously for various medical disorders. As a result, the worldwide intravenous catheter market will grow due to increasing demands for both short- and long-term healthcare due to the aging population.

Market Concentration & Characteristics

The market growth stage is high, and the pace of the market growth is accelerating. The market is characterized by a high degree of innovation owing to the rapid technological advancements driven by factors such as development of novel peripheral IV catheters, central venous catheters and midline peripheral catheters which can be used to administer fluids, medications, in the patient’s body. These catheters are coated with a medication that can be released into the bloodstream over time, which can help to reduce pain and inflammation.

The intravenous catheters industry is also characterized by the regulatory approvals received by the industry key players such as B. Braun SE, BD, Boston Scientific Corporation for the product launch. Through such activities, these companies can expand their geographic reach and enter new territories.

Growth momentum is a qualitative concept that describes the current rate or speed of growth at a particular point in time, often reflecting recent trends in growth. It is more focused on assessing the pace of growth in the near term.

The market is also subject to impact of regulations. For the medical device industry, regulations are crucial for ensuring the effectiveness and safety of devices. Medical device manufacturers are bound by stringent quality and safety regulations imposed by regulatory agencies like the European Medicines Agency and the U.S. FDA. For manufacturers to receive regulatory clearance for their intravenous catheters, they must comply with certain guidelines. Catheters with specific features are currently being developed to cater to the unique requirements of various patient groups. This includes individuals who require long-term IV therapy, have trouble gaining venous access, or pediatric patients requiring catheters. This enhances product expansion. Regional expansion is a significant factor in the market. The developing healthcare sectors of emerging nations, including India, and Brazil, are boosting up demand for IV catheters. To achieve this untapped potential, manufacturers are entering into these sectors.

Type Insights

Based on type, the market is segmented into peripheral catheters, midline peripheral catheters, and central venous catheters. In 2023, peripheral catheters segment dominated the market with a share of around 41.0%. Peripheral catheters (PIVCs) are easy to install and remove. PIVCs offer a more comfortable and minimally invasive method of obtaining therapy, which can contribute to an increase in patient satisfaction. For instance, as per an article published in 2023, National Library of Medicine stated that, with a 35-50% failure rate overall, PIVCs are the most widely used invasive medical device in healthcare.

The cost of peripheral catheters is low in comparison to the midline peripheral catheters and central venous catheters. For instance, in the U.S., the average price of a simple "first stick" peripheral IV catheter placement is approximately USD 28 to USD 35. Thus, the peripheral IV catheters are cost-effective and have minimal failure rate which drives the segment growth with increasing demand and adoption of PVICs by the consumers.

A variety of strategic initiatives by players in the industry, including the introduction of novel products, partnerships, and mergers and acquisitions, may encourage segment expansion over the forecast period. In July 2022, B. Braun SE launched the Introcan Safety 2 IV Catheter, a device that provides one-time blood control. This peripheral catheter makes intravenous (IV) access safer for the physician, which reduces the risk of injury from needle sticks and blood exposure. The adoption of minimally invasive procedures is rising due to their shorter recovery periods, less discomfort, and lower risk of problems. PIVCs are frequently utilized to deliver anesthetic and drugs during minimally invasive operations.

Whereas the central venous catheters (CVCs) segment is expected to grow at the highest CAGR over the forecast period. For patients requiring long-term intravenous therapy, CVCs are used to provide fluids, medicines, and nutrition. It is also used to collect blood samples and monitor blood pressure. Bloodstream infections, pneumothorax, and catheter-related thrombosis are some of the complications associated with CVCs. To evaluate novel approaches that prevent these problems and enhance patient outcomes, clinical research is being carried out.

Thus, the increasing number of clinical studies is expected to boost the segment growth in the near future. In April 2023, Using Bactiguard's preventive infection coat technology (BIP CVC), central venous catheters have been proven to be effective. Bactiguard announced the beginning of a clinical trial that will compare the BIP CVC against a regular catheter that is not coated. The primary objective of the study is to investigate the thrombosis rate and catheter-associated circulatory system infections.

End-use Insights

Hospital pharmacies segment held the largest market share in 2023 and is expected to grow at the highest compound annual growth rate over the forecast period. This is attributed to the increasing rates of hospitalization globally and a rise in medical procedures involving the infusion of IV fluids and solutions using catheters. The majority of IV catheter sales currently occur in hospitals, and this trend is expected to continue to do so in the coming years.

Hospital pharmacy and stores are located on the hospital premises; they handle both the distribution and storage of inpatient pharmaceuticals. The expansion of this market is mostly driven by hospital stores, which typically sell a wide variety of pharmaceuticals, including more specialized and experimental medications. Since hospitals are concerned about patient safety, they have been looking for IV catheters with less potential for infection or complications. For this purpose, IV catheters with antimicrobial coatings and needleless connectors are becoming more and more in demand from hospitals & pharmacies.

Whereas the others segment is expected to grow at the highest CAGR over the forecast period. It includes drug stores and online stores. Since there are numerous online stores that sell numerous varieties of catheters. For instance, Amazon, Shop Catheters, and Allegro Medical Supplies Inc. are a few of the prominent online sellers that provide significant discounts, warranties, and fast customer support on a range of catheters. Also, the ease of buying from home that e-commerce sites provide is especially appealing for people who are ill and find it difficult to travel to a physical store. This could increase the products' sales through these sales channels boosting the segment's growth as an outcome during the projected period.

Regional Insights

North America dominated the market in 2023. This is attributed to factors such as increasing prevalence of chronic disorders, rising geriatric population, and owing to the presence of key manufacturers such as Boston Scientific Corporation, BD, Teleflex Incorporated positively influencing the regional growth. Favorable government policies, growing public awareness, the abundance of highly qualified medical professionals, and the existence of renowned healthcare facilities contribute to the growth of the market in North America. The U.S. accounted for the largest share of the market in North America in 2023. Health spending in the U.S. was projected by the Centers for Medicare & Medicaid Services (CMS) to be 7.5% in 2022.

Asia Pacific is expected to grow at the highest CAGR over the forecast period. The demand for intravenous catheters in this region is predicted to increase as consumer awareness increases. Regional growth is also positively impacted by the expanding medical device portfolio, rising number of surgeries, and government partnerships. In March 2022, The prime ministers of Japan and India approved a five-year financial plan and an investment of USD 42 billion for a joint venture to manufacture medical devices in India. India’s healthcare system is witnessing a transition in service portfolio from nursing care to preventive care in disease management because of rising healthcare expenditure. Rising government initiatives for better healthcare infrastructure, and benefits associated with treatment of chronic disorders in China, Japan are among the factors expected to propel market growth.

Key Companies & Market Share Insights

• Boston Scientific Corporation and B Braun SE are some of the dominant players operating in the intravenous catheters market.

• Boston Scientific Corporation has a global presence and operates in approximately 100 countries. It has a wide range of IV catheters and peripheral intravenous catheters products specifically designed for interventional cardiology and radiology among others.

• B Braun SE is dedicated to developing products related to human health and well-being. The company offers medical devices and surgical products for intensive care, cardiology, urology, nephrology among others.

• Medilivescare Manufacturing Pvt. Ltd. and TuCann Medical are some of the emerging market players functioning in the intravenous catheters market.

• TuCann Medical is dedicated in manufacturing medical devices for healthcare sector. The product portfolio of the company majorly involves the creation of modified IV cannula specifically designed to reduce bloodstream infection.

• Medilivescare Manufacturing Pvt. Ltd. is involved in the creation and production of devices such as IV catheters and other surgical implants. Its primary area of expertise is in the production of infusion therapy products, and accessories.

Recent Developments

• In October 2023, Linear Health Sciences declared that the device Orchid SRV safety release valve received U.S. FDA approval. The device was approved for use with all IV access techniques, the catheter aimed to lower the risk of IV catheter failure and repair in hospitals.

• In April 2023, BD launched an entirely novel, user-friendly advanced ultrasound machine Prevue II System with a customized probe developed to help doctors implant intravenous placements with accuracy.

• In September 2022, B. Braun SE stated that it has acquired Starboard Medical, Inc.'s cutting-edge Clik-FIX catheter protection device portfolio. With this acquisition, B. Braun expanded its track record of developing innovative products and programs that enhance patient outcomes and experiences with peripheral intravenous (IV) therapy.

• In January 2022, ICU Medical Inc. announced the acquisition of Smiths Medical from Smiths Group plc. Smith’s Medical specializes in the provision of syringe and ambulatory infusion devices, vascular access, and vital care solutions.

Intravenous Catheters Market Report Scope 

Global Intravenous Catheters Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global intravenous catheters market report based on type, end-use and region:

• Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Peripheral Catheters

  • Midline Peripheral Catheters

  • Central Venous Catheters

• End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospital Pharmacies

  • Retail Pharmacies

  • Others

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • Saudi Arabia

    • UAE

    • South Africa

    • Kuwait